Due to severe albuminuria in most pediatric patients with CAKUT and a PAX2 variant and a median age at kidney failure of 9.5 years, close monitoring starting in infancy and antiproteinuric measures should be considered and may be particularly effective. This evidence concerns the gene PAX2 and congenital anomaly of kidney and urinary tract.